1,7-Dihydroxy-2,3-dimethoxyxanthone may have medicinal use in managing inflammation, asthma, and allergy; it non-competitively but reversibly antagonizes contractions induced by chemical inflammatory mediators in the guinea pig trachea in vitro and significantly inhibits LPS-induced NO production in BV2 microglia cells.